Crenezumab

Crenezumab is a humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab was developed by the Swiss-based biopharmaceutical company AC Immune, which licensed the drug in 2006 to Genentech, Inc. Its original name RG7412 refers to its inventor at AC Immune. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid-β peptides.

单词	Crenezumab
释义	Crenezumab 英语百科 Crenezumab Crenezumab is a humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab was developed by the Swiss-based biopharmaceutical company AC Immune, which licensed the drug in 2006 to Genentech, Inc. Its original name RG7412 refers to its inventor at AC Immune. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid-β peptides.
随便看	cyanoethylated fiber cyanoethylated fibre cyanoethylated kraft paper cyanoethylated paper cyanoethylated polyamide cyanoethylated polyvinyl alcohol cyanoethylated silane cyanoethylated starch cyanoethylation cyanoethyl cellulose cyanoethyl diethyl dithiocarbamate cyano ethylene cyanoethylene cyanoethyl ether cellulose cyanoethyl methyl silicone cyanoethyls CyA NOF cyanofenphos cyanoferrate cyanoferrates Cyanoferrite cyanoform cyano formate cyanoformate cyanoformic acid